We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GEMI
1251
Gemini Space Station
GEMI
$607M
| $6.12M | ﹤0.01% |
1,436,034
+1,050,324
| +272% | +$4.95M |
|
1252
Compass Diversified
CODI
$867M
| $6.12M | ﹤0.01% |
573,693
+151,832
| +36% | +$1.66M |
|
1253
Energy Recovery
ERII
$393M
| $6.11M | ﹤0.01% |
677,248
+570,951
| +537% | +$5.43M |
|
1254
Enovis
ENOV
$1.15B
| $6.1M | ﹤0.01% |
294,445
+33,348
| +13% | +$786K |
|
1255
Ituran Location and Control
ITRN
$1.02B
| $6.06M | ﹤0.01% |
99,316
+83,997
| +548% | +$4.99M |
|
1256
Axalta
AXTA
$7.6B
| $6.02M | ﹤0.01% |
176,001
-270,980
| -61% | -$8.15M |
|
1257
InterDigital
IDCC
$8.8B
| $6.01M | ﹤0.01% |
21,221
-7,836
| -27% | -$2.33M |
|
|
LCLN
1258
Lincoln International
LCLN
$937M
| $6.01M | ﹤0.01% |
+251,670
| New | +$5.94M |
|
|
CVSA
1259
Covista Inc
CVSA
$4.26B
| $6.01M | ﹤0.01% |
48,188
+4,790
| +11% | +$577K |
|
1260
Ascendis Pharma A/S
ASND
$17.7B
| $6M | ﹤0.01% |
+22,503
| New | +$5.26M |
|
|
GLIBK
1261
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$1.03B
| $6M | ﹤0.01% |
278,092
+110,696
| +66% | +$3.11M |
|
1262
Bruker
BRKR
$8.89B
| $5.96M | ﹤0.01% |
99,032
+13,592
| +16% | +$634K |
|
1263
Alto Neuroscience
ANRO
$1.41B
| $5.95M | ﹤0.01% |
225,503
+49,156
| +28% | +$1.14M |
|
|
TECX
1264
Tectonic Therapeutic
TECX
$594M
| $5.92M | ﹤0.01% |
172,101
-57,494
| -25% | -$1.69M |
|
1265
Nexstar Media Group
NXST
$5.21B
| $5.91M | ﹤0.01% |
33,116
-12,925
| -28% | -$2.42M |
|
1266
Telecom Argentina
TEO
$5.63B
| $5.89M | ﹤0.01% |
453,296
+14,265
| +3% | +$180K |
|
1267
Select Water Solutions
WTTR
$2.68B
| $5.88M | ﹤0.01% |
+294,343
| New | +$5.15M |
|
1268
Liquidia Corp
LQDA
$6.06B
| $5.84M | ﹤0.01% |
73,289
-216,150
| -75% | -$11.6M |
|
1269
Legend Biotech
LEGN
$3.99B
| $5.84M | ﹤0.01% |
202,227
-84,896
| -30% | -$2.29M |
|
1270
Absci
ABSI
$1.53B
| $5.82M | ﹤0.01% |
502,407
-716,645
| -59% | -$4.04M |
|
1271
Sutro Biopharma
STRO
$317M
| $5.82M | ﹤0.01% |
175,246
-47,388
| -21% | -$1.48M |
|
1272
Harmony Biosciences
HRMY
$2.45B
| $5.82M | ﹤0.01% |
159,741
+10,026
| +7% | +$316K |
|
1273
Wave Life Sciences
WVE
$968M
| $5.81M | ﹤0.01% |
999,533
-790,349
| -44% | -$5.24M |
|
|
OPRA
1274
Opera Ltd
OPRA
$1.63B
| $5.79M | ﹤0.01% |
292,079
+169,150
| +138% | +$2.99M |
|
1275
Rocket Companies
RKT
$39.1B
| $5.77M | ﹤0.01% |
366,065
-15,164,567
| -98% | -$219M |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.